Is left ventricular diastolic function an independent marker of prognosis after acute myocardial infarction?

Miguel Quintana1, Magnus Edner, Thomas Kahan

  • 1Department of Cardiology, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden. miguel.quintana@labmed.ki.se

Insights

Clinical risk factors and left ventricular (LV) systolic function are key predictors of outcomes after myocardial infarction (MI). LV diastolic function, assessed by Doppler echocardiography, did not add prognostic value in this large patient cohort.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Medicine

Background:

  • Left ventricular (LV) systolic function is a known prognostic marker post-myocardial infarction (MI).
  • Previous research suggested LV diastolic function may also offer prognostic insights.
  • This study investigated LV diastolic function's prognostic role in acute MI patients receiving thrombolytic therapy.

Purpose of the Study:

  • To determine if LV diastolic function provides additional prognostic information beyond clinical risk markers and LV systolic function in acute MI patients.
  • To assess the predictive value of LV diastolic function for cardiovascular death and combined end-points after MI.

Main Methods:

  • Utilized data from 520 patients with ST-elevation MI from the ATTACC study.
  • Performed two-dimensional and Doppler echocardiography 4-10 days post-admission.
  • Followed patients for a median of 31 months for cardiovascular death and nonfatal MI.

Main Results:

  • LV systolic function indices and clinical factors (hypertension, diabetes, prior MI) were independent predictors of cardiovascular death and combined end-points.
  • A restrictive filling pattern was the only diastolic parameter predicting cardiovascular death in univariate analysis.
  • LV diastolic function did not provide additional prognostic information in multivariate analysis.

Conclusions:

  • Clinical risk indicators and LV systolic function are the primary independent predictors of adverse cardiovascular outcomes post-MI.
  • Doppler-echocardiography assessment of LV diastolic function does not enhance prognostic stratification in this patient population.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...